Bayer's MEDRAD® Centargo Multi-Patient CT Injection System Now With A Wider Range of Compatible CT Contrast Agents and Presentations

Core Insights - Bayer's MEDRAD® Centargo multi-patient CT injector has received 510(k) clearance from the U.S. FDA, allowing for the use of single-dose vials in addition to previously cleared Imaging Bulk Package presentations for various contrast agents [1] Group 1 - The FDA clearance expands the compatibility of the MEDRAD® Centargo injector to include single-dose vials for contrast agents such as Ultravist® (iopromide), Isovue® (iopamidol), Optiray® (ioversol), and Omnipaque™ (iohexol) [1]